Meaningful improvements confirmed in slow-progressor subgroup; biomarker reductions support precision-medicine approach and potential FDA accelerated pathway SEOUL, South Korea, Sept. 17 ...

Bristol Myers (BMY) is looking to boost its bottom-line growth as generic competition for legacy drugs (Revlimid, Pomalyst, ...

The big question for monday,com, as it is for so many of its peers, is whether customers will apply the same context and ...

Recently disclosed tests with the F-22 set a new record for the AIM-120 AMRAAM in 2024, part of the form, fit, function refresh (F3R) development effort.

We asked five school choice proponents to offer their advice on what the forthcoming regulations from the Department of the ...

According to the latest data from the Tianyancha APP, BYD has been granted a utility model patent for a "Button Assembly, Steering Wheel, and Vehicle," with the patent application number ...

ProKidney shows strong Phase 2 CKD data, FDA support, and cash runway, with key readouts ahead despite single-asset risks.

A decade-long journey is coming to an end for Stealth BioTherapeutics and the Barth syndrome community. Will it result in the ...

The enteric nervous system (ENS), the largest division of autonomic nervous system, is a tantalizing frontier in neuroscience. With the advent of single-cell transcriptomics, the ENS has been ...

The US FDA has granted breakthrough therapy designation to the novel antibody-drug conjugate (ADC) raludotatug deruxtecan ...

Here’s a look at what retailers like Freshies, Double Kwik, Weigel's and more are doing to be more efficient with fewer ...